Biolife solutions appoints cathy coste as director and audit committee chair

Bothell, wash. , march 18, 2025 /prnewswire/ -- biolife solutions , inc. (nasdaq: blfs ) ("biolife" or the "company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (cgt) market, announces the appointment of cathy coste to its board of directors, increasing board membership to seven.
BLFS Ratings Summary
BLFS Quant Ranking